The absence of clear-cut associations with histopathological parameters of tumor aggressiveness in several tumor entities and the lack of a prognostic significance in invasive breast cancers of no special type strongly argues against a strong and clinically relevant prognostic role of CEA expression in cancer and suggests that CEA upregulation may parallel tumor development in various cancer types. This evidence concerns the gene CEACAM5 and invasive breast carcinoma.